Sponsor or institution
Clinical trials and research at Steno Diabetes Center Copenhagen
As of November 12, 2026, Find a Trial lists 17 clinical trials run by Steno Diabetes Center Copenhagen that are recruiting, at sites in 4 countries (most in Denmark (17), Germany (1), Spain (1)). By phase: Phase 4 (3), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 4Countries
Newest trials
All recruiting trials (17)
-
Preventing device-related skin rashes in kids with type 1 diabetes using hydrocolloid vs silicone patches
This study tests whether silicone-based or hydrocolloid patches help prevent recurring skin irritation from insulin pumps or CGMs in children and teens with type 1 diabetes.
-
Health program participation in Halsnæs for people with diabetes, COPD, or heart disease
This project tests whether a municipal health program in Halsnæs helps adults with diabetes, COPD, or cardiovascular disease participate more and stay engaged.
-
Remote-patient monitoring in diabetes care shows real-world outcomes
A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.
-
Digital support to reduce salt intake for people with type 2 diabetes and kidney disease
This project will test whether a smartphone app can help people with type 2 diabetes and moderately reduced kidney function eat less salt and follow kidney-friendly protein guidance over six months.
-
Post-meal glucagon before exercise to keep glucose from dropping in type 1 diabetes
In adults with type 1 diabetes using an automated insulin delivery system, the study tests whether a small dose of glucagon given before exercise helps prevent or lessen drops in blood glucose during and after moderate exercise after a meal.
-
Optimal non-drug lifestyle changes for people with type 2 diabetes
This 12-month study will test two diet-plus-exercise programs—a carbohydrate-rich plan and a carbohydrate-reduced plan—to see if they can help people with recently diagnosed, overweight type 2 diabetes reach remission.
-
Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes
This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.
-
Biomarker-guided treatment strategy for chronic kidney disease
This trial will test whether using urine biomarkers to guide adding dapagliflozin, finerenone, and/or semaglutide can better reduce albuminuria and protect kidneys in adults with CKD.
-
Finerenone treatment for cardiovascular issues in diabetes
This study is testing if a medication called finerenone can help people with type 2 diabetes who have early signs of heart and nerve problems feel better.
-
Effects of Tirzepatide on Heart Health in Overweight Individuals
This study tests if tirzepatide can improve heart health and reduce plaque in the arteries of overweight people with stable coronary artery disease.
-
Comparing three-day and seven-day insulin infusion sets for children with Type 1 Diabetes
This study tests whether using insulin infusion sets for three days or seven days helps kids with Type 1 Diabetes avoid skin problems and works better with different types of insulin.
-
Automated insulin delivery for type 1 diabetes
This study is testing if using automated insulin delivery systems can improve sleep quality and heart health for people with type 1 diabetes compared to their usual treatment.
-
Time-restricted eating for managing type 2 diabetes
This study tests if a one-year time-restricted eating plan can help people with type 2 diabetes who are overweight or obese manage their blood sugar, lose weight, and improve their overall health.
-
Multifactorial intervention to lower cardiovascular disease risk in type 1 diabetes
This study is testing whether a combination of treatments can help people with type 1 diabetes who are at high risk for heart problems stay healthier and avoid serious issues like heart attacks and kidney failure.
-
Investigating liver disease risk in individuals with low birth weight
This study is trying to see if people who were born with low birth weight are more likely to develop liver disease later in life compared to those who were born with normal weight.
-
Liver fat in people born with low birth weight
A 4-week low-calorie diet to see if cutting calories lowers liver fat in middle-aged adults born with low birth weight who have NAFLD.
-
Detecting long-term complications of diabetes in children and adolescents
This study is trying to find early signs of long-term diabetes complications in kids and teens with type 1 diabetes to help improve their care and health.
Quick answers
How many clinical trials run by Steno Diabetes Center Copenhagen are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Denmark (17 trials), Germany (1 trial), Spain (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.